(Reuters) – Drugmakers Pfizer Inc PFE.N and BioNTech SE 22UAy.DE said on Monday that three doses of their COVID-19 vaccine generated a strong immune response in children under age 5 and was safe and well-tolerated in their clinical trial. The companies said they plan to soon…